IndraLab

Statements

ATXN3 inhibits Therapeutics. 1 / 1

| 1

eidos

"To get prepared for ataxin-3 lowering therapies in further clinical trials , our study aimed to establish sensitive methods to measure total full-length and polyQ-expanded ataxin-3 protein in PBMCs , an easily accessible human biomaterial ."

33106888

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

ATXN3 inhibits Therapeutics. 1 / 1

INDRA sources:

Databases

Reading